Jay S. Skyler
CIK: 0001236386
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 3, 2026APLT
Applied Therapeutics, Inc.
Disposition(D)Direct22.5K shares- - Feb 3, 2026APLT
Applied Therapeutics, Inc.
Tender Offer(U)Direct42.5K shares- - Dec 16, 2025SABS
SAB Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
150K shares- - Jun 9, 2025APLT
Applied Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 3, 2026 |  APLT Applied Therapeutics, Inc. | Disposition(D) | 22,500 | - | $0 | Direct |
| Feb 3, 2026 | APLT Applied Therapeutics, Inc. | Tender Offer(U) | 42,500 | - | $0 | Direct |
| Dec 16, 2025 |  SABS SAB Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 150,000 | - | - | Direct |
| Jun 9, 2025 | APLT Applied Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 200,000 | - | - | Direct |
1-4 of 4 transactions
About SKYLER JAY S
SKYLER JAY S (SEC CIK 0001236386) files insider reports with the SEC as Director of Applied Therapeutics, Inc. (APLT) and Director of SAB Biotherapeutics, Inc. (SABS).
Signal8 holds 3 ownership filings by SKYLER JAY S, all Form 4s, filed between Jun 11, 2025 and Feb 3, 2026. Those filings report 4 transactions, from Jun 9, 2025 to Feb 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SKYLER JAY S's filings is in NEW YORK, NY.
Recent filings by SKYLER JAY S
- Feb 3, 2026: Disposition to issuer transaction of APLT shares (Form 4, code D).
- Feb 3, 2026: Tender of shares transaction of APLT shares (Form 4, code U).
- Dec 16, 2025: Grant or award of SABS derivative securities (Form 4, code A).
- Jun 9, 2025: Grant or award of APLT derivative securities (Form 4, code A).
Other insiders filing for Applied Therapeutics, Inc. (APLT)
- Kanter Stacy J., Director
- Hooks Corwin Dale, Chief Commercial Officer
- Chinoporos Constantine
- Funtleyder Leslie D., Chief Financial Officer
- Bailey Evan Prescott, Chief Medical Officer
- Lerner Teena, Director